Details for New Drug Application (NDA): 208358
✉ Email this page to a colleague
The generic ingredient in TRIAMTERENE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; triamterene. There are thirty-two drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; triamterene profile page.
Summary for 208358
Tradename: | TRIAMTERENE AND HYDROCHLOROTHIAZIDE |
Applicant: | Cadila |
Ingredient: | hydrochlorothiazide; triamterene |
Patents: | 0 |
Pharmacology for NDA: 208358
Physiological Effect | Decreased Renal K+ Excretion Increased Diuresis |
Suppliers and Packaging for NDA: 208358
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TRIAMTERENE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; triamterene | CAPSULE;ORAL | 208358 | ANDA | A-S Medication Solutions | 50090-7437 | 50090-7437-0 | 30 CAPSULE in 1 BOTTLE (50090-7437-0) |
TRIAMTERENE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; triamterene | CAPSULE;ORAL | 208358 | ANDA | A-S Medication Solutions | 50090-7437 | 50090-7437-1 | 100 CAPSULE in 1 BOTTLE (50090-7437-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 25MG;37.5MG | ||||
Approval Date: | Feb 11, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription